Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Weintraub, Eric
TREETOP, NCT06367387: Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment	Recruiting	4	460	US	Patient-Oriented Dosing (POD), Pain Self-Management (PSM), Usual Care, Standard Buprenorphine Dosing Condition	Jessica Merlin, National Institute on Drug Abuse (NIDA)	Opioid Use Disorder, Chronic Pain	12/25	12/26
NCT06548490: GLP-1R Agonist Treatment for Opioid Use Disorder	Recruiting	2	200	US	Semaglutide Pen Injector, Ozempic, Placebo, Dry needle stick	Milton S. Hershey Medical Center, New York University, University of Maryland, National Institute on Drug Abuse (NIDA)	Opioid Use Disorder, Opioid Abuse and Addiction, Narcotic-Related Disorders, Substance-Related Disorders, Chemically-Induced Disorders, Mental Disorder, Opioid	11/26	11/26
PRISM, NCT05973838: Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention	Recruiting	N/A	180	US	Peer-Delivered Behavioral Activation ("Peer Activate")	University of Maryland, College Park, University of Maryland, Baltimore, Weill Medical College of Cornell University, National Institute on Drug Abuse (NIDA)	Polysubstance Addiction, Opioid Medication Assisted Treatment, Treatment Adherence, Retention in Care, Substance-Related Disorders	06/27	09/27

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Weintraub, Eric
TREETOP, NCT06367387: Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment	Recruiting	4	460	US	Patient-Oriented Dosing (POD), Pain Self-Management (PSM), Usual Care, Standard Buprenorphine Dosing Condition	Jessica Merlin, National Institute on Drug Abuse (NIDA)	Opioid Use Disorder, Chronic Pain	12/25	12/26
NCT06548490: GLP-1R Agonist Treatment for Opioid Use Disorder	Recruiting	2	200	US	Semaglutide Pen Injector, Ozempic, Placebo, Dry needle stick	Milton S. Hershey Medical Center, New York University, University of Maryland, National Institute on Drug Abuse (NIDA)	Opioid Use Disorder, Opioid Abuse and Addiction, Narcotic-Related Disorders, Substance-Related Disorders, Chemically-Induced Disorders, Mental Disorder, Opioid	11/26	11/26
PRISM, NCT05973838: Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention	Recruiting	N/A	180	US	Peer-Delivered Behavioral Activation ("Peer Activate")	University of Maryland, College Park, University of Maryland, Baltimore, Weill Medical College of Cornell University, National Institute on Drug Abuse (NIDA)	Polysubstance Addiction, Opioid Medication Assisted Treatment, Treatment Adherence, Retention in Care, Substance-Related Disorders	06/27	09/27